Ausgabe 1/2004
Inhalt (17 Artikel)
Novel non-viral method for transfection of primary leukemia cells and cell lines
Frank Schakowski, Peter Buttgereit, Martin Mazur, Angela Märten, Björn Schöttker, Marcus Gorschlüter, Ingo GH Schmidt-Wolf
Regulatable systemic production of monoclonal antibodies by in vivo muscle electroporation
Norma Perez, Pascal Bigey, Daniel Scherman, Olivier Danos, Marc Piechaczyk, Mireia Pelegrin
Recombinant adeno-associated virus type 2-mediated gene delivery into the Rpe65-/- knockout mouse eye results in limited rescue
Chooi-May Lai, Meaghan JT Yu, Meliha Brankov, Nigel L Barnett, Xiaohuai Zhou, T Michael Redmond, Kristina Narfstrom, P Elizabeth Rakoczy
Long term physiologic modification using rAAV in utero gene-therapy
Deiadra J Garrett, J Craig Cohen, Janet E Larson
The recombinant adeno-associated virus vector (rAAV2)-mediated apolipoprotein B mRNA-specific hammerhead ribozyme: a self-complementary AAV2 vector improves the gene expression
Shumei Zhong, Shihua Sun, Ba-Bie Teng
The significance of controlled conditions in lentiviral vector titration and in the use of multiplicity of infection (MOI) for predicting gene transfer events
Bing Zhang, Pat Metharom, Howard Jullie, Kay AO Ellem, Geoff Cleghorn, Malcolm J West, Ming Q Wei
A dual function fusion protein of Herpes simplex virus type 1 thymidine kinase and firefly luciferase for noninvasive in vivoimaging of gene therapy in malignant glioma
Ariane Söling, Christian Theiß, Stephanie Jungmichel, Nikolai G Rainov
Attenuation of dengue virus infection by adeno-associated virus-mediated siRNA delivery
Weidong Zhang, Rajeswari Singam, Gary Hellermann, Xiaoyuan Kong, Homero San Juan, Richard F Lockey, Shuen-Ju Wu, Kevin Porter, Shyam S Mohapatra
Durable cytotoxic immune responses against gp120 elicited by recombinant SV40 vectors encoding HIV-1 gp120 ± IL-15
Hayley J McKee, Patricia Y T'sao, Maria Vera, Puri Fortes, David S Strayer
Comparison of bovine leukemia virus (BLV) and CMV promoter-driven reporter gene expression in BLV-infected and non-infected cells
Jerome S Harms, Kurt A Eakle, Lillian S Kuo, Robert D Bremel, Gary A Splitter
Human cytokine-induced killer cells have enhanced in vitro cytolytic activity via non-viral interleukin-2 gene transfer
Srinivas Nagaraj, Carsten Ziske, Ingo GH Schmidt-Wolf
Skipping the co-expression problem: the new 2A "CHYSEL" technology
Pablo de Felipe
Improved gene delivery to human saphenous vein cells and tissue using a peptide-modified adenoviral vector
Lorraine M Work, Paul N Reynolds, Andrew H Baker
Effects of recombinant adenovirus-mediated expression of IL-2 and IL-12 in human B lymphoma cells on co-cultured PBMC
Oliver Ebert, Dorothee Wilbert, Peter Buttgereit, Carsten Ziske, Dimitri Flieger, Ingo GH Schmidt-Wolf
In vivogene targeting of IL-3 into immature hematopoietic cells through CD117 receptor mediated antibody gene delivery
Alain Chapel, Olivier Deas, Morad Bensidhoum, Sabine François, Moubarak Mouiseddine, Pascal Poncet, Antoine Dürrbach, Jocelyne Aigueperse, Patrick Gourmelon, Norbert C Gorin, François Hirsch, Dominique Thierry
DNA vaccines: designing strategies against parasitic infections
Catherine Ivory, Kris Chadee